Anavex Life Sciences (AVXL) Assets Growth (3y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.58% |
| Sep 30, 2025 | -12.07% |
| Jun 30, 2025 | -13.85% |
| Mar 31, 2025 | -9.92% |
| Dec 31, 2024 | -7.53% |
| Sep 30, 2024 | -5.69% |
| Jun 30, 2024 | -5.26% |
| Mar 31, 2024 | 20.03% |
| Dec 31, 2023 | 39.68% |
| Sep 30, 2023 | 64.72% |
| Jun 30, 2023 | 70.87% |
| Mar 31, 2023 | 72.49% |
| Dec 31, 2022 | 67.76% |
| Sep 30, 2022 | 82.00% |
| Jun 30, 2022 | 93.93% |
| Mar 31, 2022 | 98.31% |
| Dec 31, 2021 | 92.21% |
| Sep 30, 2021 | 83.38% |
| Jun 30, 2021 | 83.82% |
| Mar 31, 2021 | 47.78% |
| Dec 31, 2020 | 24.22% |
| Sep 30, 2020 | 7.46% |
| Jun 30, 2020 | 8.29% |
| Sep 30, 2019 | 38.67% |
| Jun 30, 2018 | 49.75% |
| Mar 31, 2018 | 59.65% |
| Dec 31, 2017 | 59.01% |
| Sep 30, 2017 | 55.85% |
| Jun 30, 2017 | 38.80% |
| Sep 30, 2016 | 189.02% |
| Jun 30, 2015 | 611.68% |
| Mar 31, 2015 | 221.74% |
| Sep 30, 2014 | 230.86% |